Changes in Lipoprotein Levels in Chronic Hepatitis C
Author Information
Author(s): Nishimura Motoi, Yamamoto Haruna, Yoshida Toshihiko, Seimiya Masanori, Sawabe Yuji, Matsushita Kazuyuki, Umemura Hiroshi, Sogawa Kazuyuki, Takizawa Hirotaka, Yokosuka Osamu, Nomura Fumio
Primary Institution: Chiba University, Chiba City, Japan
Hypothesis
Does the serum VLDL-TG/non-VLDL-TG ratio change in patients with chronic hepatitis C?
Conclusion
The study found that the serum VLDL-TG/non-VLDL-TG ratio decreases as early as stage F1 of chronic hepatitis C, indicating alterations in triglyceride metabolism.
Supporting Evidence
- Serum VLDL-TG levels were significantly lower in patients with non-cirrhotic chronic hepatitis C compared to healthy subjects.
- The serum VLDL-TG/non-VLDL-TG ratio decreased significantly from stage F1 onward in chronic hepatitis C patients.
- Total triglyceride levels did not show significant differences between patients and healthy subjects until cirrhosis.
Takeaway
This study shows that people with chronic hepatitis C have changes in certain fats in their blood, which can help doctors understand how the disease is progressing.
Methodology
The study measured serum VLDL-TG levels in 69 patients with chronic hepatitis C and 50 healthy subjects using a new assay protocol.
Limitations
Healthy subjects did not undergo liver biopsy to confirm normal liver function.
Participant Demographics
69 patients with chronic hepatitis C and 50 healthy subjects, with no history of excessive alcohol or drug abuse.
Statistical Information
P-Value
p<0.000001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website